False Claims Act, Qui Tam & Whistleblower Investigations

We defend companies facing federal and state False Claims Act, qui tam, and whistleblower investigations and help them navigate high-stakes government scrutiny, internal crises, and litigation. Our team combines former government officials, seasoned trial lawyers, and regulatory counsel across healthcare, life sciences, international trade, financial services, defense, and education to defend clients from investigation through trial and appeal.

We represent healthcare providers, hospital systems, life sciences companies, universities, and other businesses that do business with federal and state governments, as well as clients in defense, international trade, and financial services. Because FCA matters often turn on both legal and regulatory judgment, our litigators and investigators work closely with subject-matter lawyers to develop strategies aimed at dismissal, government declinations, favorable resolutions, and trial victories. We are equipped to manage complex investigations, sensitive matters, subpoena and discovery disputes, and appeals with a focus on achieving effective, lasting results.

Related Lawyers

Michael E. Paulhus (Mike)
Partner
Government Matters & Regulation
Paul B. Murphy
Partner
Special Matters & Government Investigations
Mark A. Jensen
Partner
Special Matters & Government Investigations
Christopher C. Burris (Chris)
Partner
Special Matters & Government Investigations
Stephanie F. Johnson
Partner
Government Matters & Regulation
Craig Carpenito
Partner
Special Matters & Government Investigations
Andrew C. Hruska (Drew)
Partner
Special Matters & Government Investigations
Jeffrey S. Bucholtz
Partner
Business Litigation
John C. Richter
Partner
Special Matters & Government Investigations

Featured Insights

Featured Events

a blue and green background
Conference
October 15, 2025
Health Law & Policy Forum West
a blue and green background
Webinar
January 28, 2025
Overpayments, Internal Investigations and FCA Updates: What Providers Need to Know for Continued Compliance in 2025

Latest News